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I Results
I Eight studies met the inclusion criteria. Seven studies reported on graft maturation with significantly better outcomes in the platelet groups in 4, and there were large differences in means in an additional 2 studies. Five studies reported on tunnel healing, and 4 found no difference between groups. Three studies assessed clinical outcome but found no differences, i regardless of whether they had shown a beneficial effect (1 of 3) or no effect (2 of 3) of platelets on graft and tunnel healing.
Conclusions
The current best evidence suggests that the addition of platelet concentrates to ACL reconstruction may have a beneficial effect I on graft maturation and could improve it by 20% to 30% on average, but with substantial variability. The most likely mode of I action is that treatment with platelets accelerates graft repopulation and remodeling, and this interpretation is supported by the I existing data and is biologically plausible. However, the current evidence also shows only a very limited influence of platelet concentrates on graft-bone interface healing and no significant difference in clinical outcomes.
Level of Evidence
I Level 111, systematic review of Level I, II, and 111 studies.
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